NCPA 2025 Recap: Ownership, AI, and Surviving the MFP Cash Crunch
Échec de l'ajout au panier.
Échec de l'ajout à la liste d'envies.
Échec de la suppression de la liste d’envies.
Échec du suivi du balado
Ne plus suivre le balado a échoué
NCPA 2025 Recap: Ownership, AI, and Surviving the MFP Cash Crunch
-
Narrateur(s):
-
Auteur(s):
À propos de cet audio
Send us a text
Schedule an Rx Assessment
Subscribe to Master The Margin
How will the Medicare Drug Price Negotiation Program reshape independent pharmacy? What should owners be doing now to prepare?
In this episode of The Bottom Line Pharmacy Podcast, Scotty Sykes, CPA, CFP®, Bonnie Bond, CPA, and Austin Murray sit down in the new studio to recap NCPA 2025 from an ownership, cash flow, and strategy lens.
We cover:
- A 50,000-foot view of the Medicare Drug Price Negotiation Program
- Key trends among startup vs. acquisition-minded owners
- Pharmacy business plans and clinical services
Stay connected with us on social media:
Facebook
More on this topic:
Podcast: The Trusted Pharmacist: Advocacy and Building a Resilient Pharmacy
Podcast: From Counter to Capitol